hair loss with semaglutide GLP-1 Loss: How Wegovy, Ozempic & Mounjaro Cause Thinning (And Ho Study Offers More Evidence That

In 2024, Wegovy received additional approval for lowering cardiovascular risk, and Zepbound was approved for treating moderate to severe obstructive sleep apnea in adults with obesity or who are overweight

The real concern is not pharmacokineticit's pharmacodynamic

Typical requirements include biopsy or MRI-PDFF confirmation of NASH with fibrosis stage F2 or higher, documentation of failed treatments (vitamin E, pioglitazone, or structured weight loss for at least 6 months), and a letter of medical necessity from a gastroenterologist or hepatologist

Patients can use sensor data to see the impact of food or activity on their glucose levels in real-time, allowing them to take actions in a timely manner